Report Detail

Request for Sample of this report

Pharma & Healthcare Global Natural Killer Cells Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4606067
    • |
  • 02 August, 2024
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Natural Killer Cells Therapeutics market size was valued at USD 360.1 million in 2023 and is forecast to a readjusted size of USD 999.2 million by 2030 with a CAGR of 15.7% during review period.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
A significant driver in the Natural Killer Cells Therapeutics market is the growing interest in immunotherapy approaches for cancer treatment. Natural killer (NK) cell-based therapeutics have emerged as a promising strategy to harness the body's immune system to combat cancer. However, a notable challenge in this market is the need for scalability and manufacturing standardization. Ensuring that NK cell therapies can be produced reliably at scale while addressing challenges related to cell expansion, quality control, and patient-specific manufacturing poses a significant challenge. Researchers and manufacturers must invest in technology advancements, quality assurance processes, and regulatory compliance to make NK cell-based therapeutics widely accessible and consistently effective in the fight against cancer.
The Global Info Research report includes an overview of the development of the Natural Killer Cells Therapeutics industry chain, the market status of Cancer (NK Cell Therapies, NK Cell Directed Antibodies), Gastrointestinal Diseases (NK Cell Therapies, NK Cell Directed Antibodies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Natural Killer Cells Therapeutics.
Regionally, the report analyzes the Natural Killer Cells Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Natural Killer Cells Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Natural Killer Cells Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Natural Killer Cells Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., NK Cell Therapies, NK Cell Directed Antibodies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Natural Killer Cells Therapeutics market.
Regional Analysis: The report involves examining the Natural Killer Cells Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Natural Killer Cells Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Natural Killer Cells Therapeutics:
Company Analysis: Report covers individual Natural Killer Cells Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Natural Killer Cells Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Gastrointestinal Diseases).
Technology Analysis: Report covers specific technologies relevant to Natural Killer Cells Therapeutics. It assesses the current state, advancements, and potential future developments in Natural Killer Cells Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Natural Killer Cells Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Natural Killer Cells Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Market segment by Application
Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders
Others
Market segment by players, this report covers
Affimed
Celgene
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Natural Killer Cells Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Natural Killer Cells Therapeutics, with revenue, gross margin and global market share of Natural Killer Cells Therapeutics from 2019 to 2024.
Chapter 3, the Natural Killer Cells Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Natural Killer Cells Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Natural Killer Cells Therapeutics.
Chapter 13, to describe Natural Killer Cells Therapeutics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Natural Killer Cells Therapeutics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Natural Killer Cells Therapeutics by Type
    • 1.3.1 Overview: Global Natural Killer Cells Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Natural Killer Cells Therapeutics Consumption Value Market Share by Type in 2023
    • 1.3.3 NK Cell Therapies
    • 1.3.4 NK Cell Directed Antibodies
  • 1.4 Global Natural Killer Cells Therapeutics Market by Application
    • 1.4.1 Overview: Global Natural Killer Cells Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Cancer
    • 1.4.3 Gastrointestinal Diseases
    • 1.4.4 Immunoproliferative Disorders
    • 1.4.5 Others
  • 1.5 Global Natural Killer Cells Therapeutics Market Size & Forecast
  • 1.6 Global Natural Killer Cells Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global Natural Killer Cells Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Natural Killer Cells Therapeutics Market Size by Region, (2019-2030)
    • 1.6.3 North America Natural Killer Cells Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Natural Killer Cells Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Natural Killer Cells Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Natural Killer Cells Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Natural Killer Cells Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Affimed
    • 2.1.1 Affimed Details
    • 2.1.2 Affimed Major Business
    • 2.1.3 Affimed Natural Killer Cells Therapeutics Product and Solutions
    • 2.1.4 Affimed Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Affimed Recent Developments and Future Plans
  • 2.2 Celgene
    • 2.2.1 Celgene Details
    • 2.2.2 Celgene Major Business
    • 2.2.3 Celgene Natural Killer Cells Therapeutics Product and Solutions
    • 2.2.4 Celgene Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Celgene Recent Developments and Future Plans
  • 2.3 Fate Therapeutics
    • 2.3.1 Fate Therapeutics Details
    • 2.3.2 Fate Therapeutics Major Business
    • 2.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Product and Solutions
    • 2.3.4 Fate Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Fate Therapeutics Recent Developments and Future Plans
  • 2.4 Fortress Biotech
    • 2.4.1 Fortress Biotech Details
    • 2.4.2 Fortress Biotech Major Business
    • 2.4.3 Fortress Biotech Natural Killer Cells Therapeutics Product and Solutions
    • 2.4.4 Fortress Biotech Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Fortress Biotech Recent Developments and Future Plans
  • 2.5 Glycostem Therapeutics
    • 2.5.1 Glycostem Therapeutics Details
    • 2.5.2 Glycostem Therapeutics Major Business
    • 2.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Product and Solutions
    • 2.5.4 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Glycostem Therapeutics Recent Developments and Future Plans
  • 2.6 Innate Pharma
    • 2.6.1 Innate Pharma Details
    • 2.6.2 Innate Pharma Major Business
    • 2.6.3 Innate Pharma Natural Killer Cells Therapeutics Product and Solutions
    • 2.6.4 Innate Pharma Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Innate Pharma Recent Developments and Future Plans
  • 2.7 Nantkwest
    • 2.7.1 Nantkwest Details
    • 2.7.2 Nantkwest Major Business
    • 2.7.3 Nantkwest Natural Killer Cells Therapeutics Product and Solutions
    • 2.7.4 Nantkwest Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Nantkwest Recent Developments and Future Plans
  • 2.8 Nkarta Therapeutics
    • 2.8.1 Nkarta Therapeutics Details
    • 2.8.2 Nkarta Therapeutics Major Business
    • 2.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Product and Solutions
    • 2.8.4 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Nkarta Therapeutics Recent Developments and Future Plans
  • 2.9 NKT Therapeutics
    • 2.9.1 NKT Therapeutics Details
    • 2.9.2 NKT Therapeutics Major Business
    • 2.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Product and Solutions
    • 2.9.4 NKT Therapeutics Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 NKT Therapeutics Recent Developments and Future Plans
  • 2.10 Ziopharm Oncology
    • 2.10.1 Ziopharm Oncology Details
    • 2.10.2 Ziopharm Oncology Major Business
    • 2.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Product and Solutions
    • 2.10.4 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Ziopharm Oncology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Natural Killer Cells Therapeutics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Natural Killer Cells Therapeutics by Company Revenue
    • 3.2.2 Top 3 Natural Killer Cells Therapeutics Players Market Share in 2023
    • 3.2.3 Top 6 Natural Killer Cells Therapeutics Players Market Share in 2023
  • 3.3 Natural Killer Cells Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 Natural Killer Cells Therapeutics Market: Region Footprint
    • 3.3.2 Natural Killer Cells Therapeutics Market: Company Product Type Footprint
    • 3.3.3 Natural Killer Cells Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Natural Killer Cells Therapeutics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Natural Killer Cells Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Natural Killer Cells Therapeutics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Natural Killer Cells Therapeutics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Natural Killer Cells Therapeutics Consumption Value by Type (2019-2030)
  • 6.2 North America Natural Killer Cells Therapeutics Consumption Value by Application (2019-2030)
  • 6.3 North America Natural Killer Cells Therapeutics Market Size by Country
    • 6.3.1 North America Natural Killer Cells Therapeutics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Natural Killer Cells Therapeutics Consumption Value by Type (2019-2030)
  • 7.2 Europe Natural Killer Cells Therapeutics Consumption Value by Application (2019-2030)
  • 7.3 Europe Natural Killer Cells Therapeutics Market Size by Country
    • 7.3.1 Europe Natural Killer Cells Therapeutics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.3 France Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Natural Killer Cells Therapeutics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Natural Killer Cells Therapeutics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific Natural Killer Cells Therapeutics Consumption Value by Region (2019-2030)
    • 8.3.2 China Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.5 India Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Natural Killer Cells Therapeutics Consumption Value by Type (2019-2030)
  • 9.2 South America Natural Killer Cells Therapeutics Consumption Value by Application (2019-2030)
  • 9.3 South America Natural Killer Cells Therapeutics Market Size by Country
    • 9.3.1 South America Natural Killer Cells Therapeutics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Natural Killer Cells Therapeutics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Natural Killer Cells Therapeutics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa Natural Killer Cells Therapeutics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Natural Killer Cells Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Natural Killer Cells Therapeutics Market Drivers
  • 11.2 Natural Killer Cells Therapeutics Market Restraints
  • 11.3 Natural Killer Cells Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Natural Killer Cells Therapeutics Industry Chain
  • 12.2 Natural Killer Cells Therapeutics Upstream Analysis
  • 12.3 Natural Killer Cells Therapeutics Midstream Analysis
  • 12.4 Natural Killer Cells Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Natural Killer Cells Therapeutics. Industry analysis & Market Report on Natural Killer Cells Therapeutics is a syndicated market report, published as Global Natural Killer Cells Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Natural Killer Cells Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,641.32
    		3,961.98
    		5,282.64
    		3,128.52
    		4,692.78
    		6,257.04
    		492,802.80
    		739,204.20
    		985,605.60
    		291,728.40
    		437,592.60
    		583,456.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo